Sign In
Buy ICAD
$3.87
+0 (+0%)
At Close: Oct 16, 2025
UPDATE -- iCAD to Report Fourth Quarter 2019 Financial Results on Thursday, February 27
02:18pm, Thursday, 13'th Feb 2020
NASHUA, N.H., Feb. 13, 2020 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that.
iCAD to Report Fourth Quarter 2019 Financial Results on Thursday, February 27, 2020
01:00pm, Thursday, 13'th Feb 2020
NASHUA, N.H., Feb. 13, 2020 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that.
iCAD to Participate in the 40th Annual Cowen Healthcare Conference
01:00pm, Wednesday, 12'th Feb 2020
NASHUA, N.H., Feb. 12, 2020 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that.
94 Biggest Movers From Yesterday
10:13am, Wednesday, 12'th Feb 2020
Gainers
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license agreement with Zhejiang HaiChang Biotechnology....
First Brain Tumor Treated with Xoft IORT in the United States
01:00pm, Tuesday, 11'th Feb 2020
NASHUA, N.H., Feb. 11, 2020 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the.
iCAD Says First Metastatic Brain Tumor Has Been Treated In US Using Xoft IORT
12:00am, Tuesday, 11'th Feb 2020's Top Upgrades, Downgrades For February 5, 2020
02:55pm, Wednesday, 05'th Feb 2020
Upgrades
Susquehanna upgraded the stock for MercadoLibre Inc (NASDAQ: MELI) from Neutral to Positive. In the third quarter, MercadoLibre showed an EPS of ($0.95),...
JMP Securities Initiates Coverage On icad with Market Outperform Rating, Announces $15 Price Target
12:00am, Wednesday, 05'th Feb 20204 Health Information Services Stocks Moving In Monday's Session
05:28pm, Monday, 27'th Jan 2020
Gainers
• icad, Inc. (NASDAQ:ICAD) shares moved upwards by 4.7% to $9.10 during Monday's regular session. The most recent rating by Dougherty & Co., on December 20,...
NASHUA, N.H., Jan. 27, 2020 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it.
6 Health Information Services Stocks Moving In Wednesday's Session
06:28pm, Wednesday, 22'nd Jan 2020
Gainers
• 10x Genomics, Inc. (NASDAQ:TXG) stock moved upwards by 8.3% to $95.04 during Wednesday's regular session. The most recent rating by Citigroup, on January 07, is...
iCAD Appoints Nathaniel Dalton to its Board of Directors
01:00pm, Monday, 13'th Jan 2020
NASHUA, N.H., Jan. 13, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Nathaniel Dalton wa
